Stocks and Investing Stocks and Investing
Thu, July 16, 2020
Wed, July 15, 2020

Andrew Berens Maintained (BPMC) at Buy with Increased Target to $106 on, Jul 15th, 2020


Published on 2024-10-27 09:43:06 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $105 to $106 on, Jul 15th, 2020.

Andrew has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Initiated at Hold and Held Target at $59 on, Tuesday, May 5th, 2020


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Konstantinos Aprilakis of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $85 on, Monday, June 8th, 2020
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, April 30th, 2020
  • George Farmer of "BMO Capital" Maintained at Buy with Decreased Target to $75 on, Wednesday, April 29th, 2020

Contributing Sources